Skip to content

Drug interactions

Deferiprone + Irinotecan

Severity: Major

Deferiprone and Irinotecan: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can cause neutropenia, and deferiprone may lead to agranulocytosis. Together they may cause additive bone marrow suppression and serious infection.

What this interaction means in plain words

Deferiprone and Irinotecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Deferiprone belongs to Miscellaneous; Irinotecan belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic myelosuppression.

What to do

Avoid the combination if possible. If it cannot be avoided, monitor absolute neutrophil count more frequently and interrupt deferiprone if infection or neutropenia develops.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deferiprone and Irinotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deferiprone with Irinotecan?

MediHelp rates the interaction as major. Deferiprone and Irinotecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs can cause neutropenia, and deferiprone may lead to agranulocytosis. Together they may cause additive bone marrow suppression and serious infection.

How serious is the interaction between Deferiprone and Irinotecan?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If it cannot be avoided, monitor absolute neutrophil count more frequently and interrupt deferiprone if infection or neutropenia develops.

What other medicines interact with Irinotecan?

MediHelp also lists interactions of Irinotecan with, for example, Clozapine, Sacituzumab govitecan, Adenovirus types 4 and 7 live. The full list is on the Irinotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in